Blog

(From : http://feeds.feedburner.com - February 17 , 2017 )

The Federal Circuit upheld the decision of the Patent Trial and Appeal Board (“Board”), on Inter Partes Review, to invalidate as anticipated or obvious all claims of a patent owned by MPHJ Technology Investments.

(From : http://www.managingip.com - February 17 , 2017 )

While 2016 was a quiet year for design decisions in the Court of Justice, 2017 looks to be a cracker year of important cases. In the first of two articles, David Stone looks back at the year that was.

(From : http://feeds.feedburner.com - February 17 , 2017 )

By Kevin E. Noonan -- Yesterday, the Patent Trial and Appeal Board (PTAB) of the U.S.

(From : http://feeds.feedburner.com - February 16 , 2017 )

With respect to the thorny issue of patent litigation, Senator Hatch explained that there is a very real chance that venue reform will happen this year...

(From : http://www.ip-watch.org - February 16 , 2017 )

The concept of machines that can think and create in ways that are indistinguishable from humans has been the stuff of science fiction for decades.

(From : http://feeds2.feedburner.com - February 16 , 2017 )

The concept of machines that can think and create in ways that are indistinguishable from humans has been the stuff of science fiction for decades.

(From : http://docketreport.blogspot.com - February 16 , 2017 )
(From : http://www.managingip.com - February 16 , 2017 )

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion.

(From : http://feeds.feedburner.com - February 16 , 2017 )

The PTAB concluded: "Based on our determination that the preponderance of the evidence shows there is no interference-in-fact between the parties’ claims, we need not decide the other pending motions."...

(From : http://docketreport.blogspot.com - February 16 , 2017 )

The court granted defendant's motion to exclude the testimony of plaintiff's survey expert regarding one of the patents-in-suit, and all related damages estimates, as unreliable because it was based on a rejected claim construction.